Clinical Trial Update: Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the effect of renin-angiotensin system blockade on Fas (CD95) and asymmetric dimethylarginine (ADMA) levels in type 2 diabetes pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Renin-Angiotensin System blockade

Snippet

Sponsor: Gulhane School of Medicine | Conditions: Proteinuria, Diabetic Nephropathy | Phase 4 | Status: COMPLETED